Daehan New Pharm Co Ltd - ESG Rating & Company Profile powered by AI
Other companies in the scoring peer group for Daehan New Pharm Co Ltd are displayed below. This analysis of Daehan New Pharm Co Ltd was assembled by All Street Sevva using proprietary AI. If you are employed by Daehan New Pharm Co Ltd and you would like to licence your Sustainability rating, please contact us.
Daehan New Pharm Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.0; made up of an environmental score of 5.3, social score of 1.6 and governance score of 2.0.
3.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1309 | Willow Biosciences Inc | 3.1 | Medium |
1309 | biOasis Technologies Inc | 3.1 | Medium |
1336 | Daehan New Pharm Co Ltd | 3.0 | Medium |
1336 | BridgeBio Pharma Inc | 3.0 | Medium |
1336 | Absci Corp | 3.0 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Daehan New Pharm Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Daehan New Pharm Co Ltd disclose current and historical energy intensity?
Does Daehan New Pharm Co Ltd report the average age of the workforce?
Does Daehan New Pharm Co Ltd reference operational or capital allocation in relation to climate change?
Does Daehan New Pharm Co Ltd disclose its ethnicity pay gap?
Does Daehan New Pharm Co Ltd disclose cybersecurity risks?
Does Daehan New Pharm Co Ltd offer flexible work?
Does Daehan New Pharm Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Daehan New Pharm Co Ltd disclose the number of employees in R&D functions?
Does Daehan New Pharm Co Ltd conduct supply chain audits?
Does Daehan New Pharm Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Daehan New Pharm Co Ltd conduct 360 degree staff reviews?
Does Daehan New Pharm Co Ltd disclose the individual responsible for D&I?
Does Daehan New Pharm Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Daehan New Pharm Co Ltd disclose current and / or historical scope 2 emissions?
Does Daehan New Pharm Co Ltd disclose water use targets?
Does Daehan New Pharm Co Ltd have careers partnerships with academic institutions?
Did Daehan New Pharm Co Ltd have a product recall in the last two years?
Does Daehan New Pharm Co Ltd disclose incidents of discrimination?
Does Daehan New Pharm Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Daehan New Pharm Co Ltd issued a profit warning in the past 24 months?
Does Daehan New Pharm Co Ltd disclose parental leave metrics?
Does Daehan New Pharm Co Ltd disclose climate scenario or pathway analysis?
Does Daehan New Pharm Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Daehan New Pharm Co Ltd disclose the pay ratio of women to men?
Does Daehan New Pharm Co Ltd support suppliers with sustainability related research and development?
Does Daehan New Pharm Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Daehan New Pharm Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Daehan New Pharm Co Ltd involved in embryonic stem cell research?
Does Daehan New Pharm Co Ltd disclose GHG and Air Emissions intensity?
Does Daehan New Pharm Co Ltd disclose its waste policy?
Does Daehan New Pharm Co Ltd report according to TCFD requirements?
Does Daehan New Pharm Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Daehan New Pharm Co Ltd disclose energy use targets?
Does Daehan New Pharm Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Daehan New Pharm Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Daehan New Pharm Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Daehan New Pharm Co., Ltd. manufactures and sells pharmaceuticals and animal health products in South Korea and internationally. The company offers pharmaceutical products, including cardiovascular, endocrine, neuropsychiatric, gastrointestinal, respiratory, musculoskeletal, osteoporosis, anti-cancer, urogenital, antifungal, antiviral hormone, dermatologic, central nervous, hormone, and antiobesity drugs, as well as antipyretic, analgesic, anti-inflammatory, and anti-infective drugs. It also provides antibiotics, antineoplastic, anticonvulsives, vitamins and others, amino acids, anesthetics, and inorganic products. In addition, the company offers animal health and nutrition products for poultry, cattle, sheep, swine, and fish; health supplements; and medical devices, as well as develops serum-free media for clinical application and fibroblast-based cell therapy. Daehan New Pharm Co., Ltd. was incorporated in 1984 and is headquartered in Hwaseong-si, South Korea.